PHAT
Price
$12.36
Change
-$0.08 (-0.64%)
Updated
Aug 28 closing price
Capitalization
876.86M
69 days until earnings call
TNFA
Price
$0.06
Change
-$0.03 (-33.33%)
Updated
Aug 28 closing price
Capitalization
873.74K
Interact to see
Advertisement

PHAT vs TNFA

Header iconPHAT vs TNFA Comparison
Open Charts PHAT vs TNFABanner chart's image
Phathom Pharmaceuticals
Price$12.36
Change-$0.08 (-0.64%)
Volume$628.82K
Capitalization876.86M
TNF Pharmaceuticals
Price$0.06
Change-$0.03 (-33.33%)
Volume$129.97M
Capitalization873.74K
PHAT vs TNFA Comparison Chart in %
Loading...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHAT vs. TNFA commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHAT is a StrongBuy and TNFA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (PHAT: $12.36 vs. TNFA: $0.06)
Brand notoriety: PHAT and TNFA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHAT: 63% vs. TNFA: 187%
Market capitalization -- PHAT: $876.86M vs. TNFA: $873.74K
PHAT [@Biotechnology] is valued at $876.86M. TNFA’s [@Biotechnology] market capitalization is $873.74K. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHAT’s FA Score shows that 0 FA rating(s) are green whileTNFA’s FA Score has 1 green FA rating(s).

  • PHAT’s FA Score: 0 green, 5 red.
  • TNFA’s FA Score: 1 green, 4 red.
According to our system of comparison, both PHAT and TNFA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHAT’s TA Score shows that 5 TA indicator(s) are bullish while TNFA’s TA Score has 4 bullish TA indicator(s).

  • PHAT’s TA Score: 5 bullish, 4 bearish.
  • TNFA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PHAT is a better buy in the short-term than TNFA.

Price Growth

PHAT (@Biotechnology) experienced а +12.88% price change this week, while TNFA (@Biotechnology) price change was -17.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Reported Earning Dates

PHAT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($877M) has a higher market cap than TNFA($874K). PHAT YTD gains are higher at: 52.217 vs. TNFA (-94.643). TNFA has higher annual earnings (EBITDA): -8.35M vs. PHAT (-256.76M). PHAT has more cash in the bank: 150M vs. TNFA (5.88M). TNFA has less debt than PHAT: TNFA (2.68K) vs PHAT (206M). PHAT has higher revenues than TNFA: PHAT (114M) vs TNFA (0).
PHATTNFAPHAT / TNFA
Capitalization877M874K100,343%
EBITDA-256.76M-8.35M3,076%
Gain YTD52.217-94.643-55%
P/E RatioN/AN/A-
Revenue114M0-
Total Cash150M5.88M2,551%
Total Debt206M2.68K7,692,308%
FUNDAMENTALS RATINGS
PHAT vs TNFA: Fundamental Ratings
PHAT
TNFA
OUTLOOK RATING
1..100
2516
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
8
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3597
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TNFA's Valuation (8) in the null industry is significantly better than the same rating for PHAT (77). This means that TNFA’s stock grew significantly faster than PHAT’s over the last 12 months.

TNFA's Profit vs Risk Rating (100) in the null industry is in the same range as PHAT (100). This means that TNFA’s stock grew similarly to PHAT’s over the last 12 months.

TNFA's SMR Rating (100) in the null industry is in the same range as PHAT (100). This means that TNFA’s stock grew similarly to PHAT’s over the last 12 months.

PHAT's Price Growth Rating (35) in the null industry is somewhat better than the same rating for TNFA (97). This means that PHAT’s stock grew somewhat faster than TNFA’s over the last 12 months.

PHAT's P/E Growth Rating (100) in the null industry is in the same range as TNFA (100). This means that PHAT’s stock grew similarly to TNFA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHATTNFA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PZG0.990.04
+4.42%
Paramount Gold Nevada Corp
ERJ56.450.60
+1.07%
Embraer SA
EGY3.900.03
+0.78%
Vaalco Energy
CHSCP28.75-0.14
-0.48%
CHS
HUN10.89-0.10
-0.91%
Huntsman Corp

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with TNFA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then TNFA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
-0.64%
TNFA - PHAT
39%
Loosely correlated
-31.56%
ATRA - PHAT
36%
Loosely correlated
+0.08%
RGNX - PHAT
35%
Loosely correlated
+2.15%
URGN - PHAT
34%
Loosely correlated
-1.54%
ACIU - PHAT
32%
Poorly correlated
-0.97%
More

TNFA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNFA has been loosely correlated with ARTV. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TNFA jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNFA
1D Price
Change %
TNFA100%
-31.56%
ARTV - TNFA
47%
Loosely correlated
-3.36%
COGT - TNFA
39%
Loosely correlated
-2.34%
PHAT - TNFA
39%
Loosely correlated
-0.64%
TVGN - TNFA
36%
Loosely correlated
-1.88%
LRMR - TNFA
32%
Poorly correlated
+0.26%
More